EIF3J
Eukaryotic translation initiation factor 3 subunit J
Also known as: eIF3-alpha, eIF3-p35, EIF3J_HUMAN, EIF3S1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75822
- Gene
- EIF3J
- Ensembl
- ENSG00000104131
- Chromosome
- 15
- Canonical length
- 258 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a core subunit of the eukaryotic initiation factor 3 complex, which participates in the initiation of translation by aiding in the recruitment of protein and mRNA components to the 40S ribosome. There are pseudogenes for this gene on chromosomes 1, 3, and 9. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2013]
Canonical amino-acid sequenceUniProt
258 residues, UniProt reviewed canonical sequence.
>O75822|EIF3J
1 MAAAAAAAGD SDSWDADAFS VEDPVRKVGG GGTAGGDRWE GEDEDEDVKD NWDDDDDEKK
61 EEAEVKPEVK ISEKKKIAEK IKEKERQQKK RQEEIKKRLE EPEEPKVLTP EEQLADKLRL
121 KKLQEESDLE LAKETFGVNN AVYGIDAMNP SSRDDFTEFG KLLKDKITQY EKSLYYASFL
181 EVLVRDVCIS LEIDDLKKIT NSLTVLCSEK QKQEKQSKAK KKKKGVVPGG GLKATMKDDL
241 ADYGGYDGGY VQDYEDFMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EIF3J can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 196 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 196 nTPM
- tongue: 97 nTPM
- pancreas: 62 nTPM
- liver: 55 nTPM
- salivary gland: 53 nTPM
- spinal cord: 49 nTPM
Single-cell type
- hepatocytes: 394 nCPM
- esophageal apical cells: 344 nCPM
- pancreatic acinar cells: 343 nCPM
- syncytiotrophoblasts: 289 nCPM
- oocytes: 286 nCPM
- ocular epithelial cells: 270 nCPM
Immune cell
- plasmacytoid DC: 77 nTPM
- basophil: 64 nTPM
- NK-cell: 61 nTPM
- memory B-cell: 59 nTPM
- naive B-cell: 54 nTPM
- T-reg: 53 nTPM
Brain region
- cerebral cortex: 64 nTPM
- midbrain: 63 nTPM
- pons: 59 nTPM
- white matter: 59 nTPM
- medulla oblongata: 56 nTPM
- hypothalamus: 56 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.86
- gnomAD missense Z
- 1.21
- DepMap mean gene effect
- -0.58
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Eukaryotic translation initiation factor 3 subunit J
- Eukaryotic translation initiation factor 3-like domain superfamily
- Translation initiation factor eIF3 subunit
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EIF3J in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EIF3J as an antibody target. Whether an autoantibody or antibody against EIF3J could matter depends on whether native EIF3J is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EIF3J is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EIF3J as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...